1 recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Recruiting 1 |
Follow Jason Careri: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Caplyta Versus Placebo for Adults With Social Anxiety Disorder Lumateperone 42 mg, Placebo - Social Anxiety Disorder (SAD) | Phase 4 | Recruiting | Jason Careri | 40 | 2026-09-10 | 2026-09-15 |
Phobia, Social (1)
lumateperone (1)
United States (1)